imexam software inc.

iData Research at IDS 2025 (Day 4) continues our coverage of the world’s largest dental trade fair in Cologne, Germany.  Day 4 was defined by a surge in 3D printing innovation, highlighting compact chairside units, faster curing systems, AI-assisted workflow tools, and next-gen dental materials.  As exhibitors push the boundaries of digital fabrication, the technology The post iData Research at IDS 2025 (Day 4): Compact 3D Systems, Workflow Automation, and Digital Efficiency appeared first on iData Research.

iData Research at IDS 2025 (Day 3) continues our on-site coverage from Cologne, Germany, where the world’s largest dental trade fair is showcasing the latest in oral healthcare innovation. With over 2,000 exhibitors and thousands of professionals in attendance, Day 3 highlighted next-gen dental technologies, AI-powered workflows, and the latest intraoral scanning, imaging, and biomaterial The post iData Research at IDS 2025 (Day 3): AI-Powered Workflows and Next-Gen Dental Tech appeared first on iData Research.

iData Research at IDS 2025 in Cologne, Germany – the world’s leading trade fair for the dental industry.  With over 2,000 exhibitors and tens of thousands of attendees from across the globe, IDS 2025 is a hub of cutting-edge dental technologies, market shifts, and key business partnerships.   Book a Demo   Table of Contents The post iData Research at IDS 2025 (Days 1 – 2): The Latest in Imaging, AI, and 3D Dental Tech appeared first on iData Research.

AI in market research is evolving rapidly, with platforms like ChatGPT, DeepSeek, and other large language models now being used to draft reports, summarize market trends, and even estimate forecasts. Their speed and accessibility have made them attractive tools for many industries, including healthcare and MedTech. But when accuracy, traceability, and methodology matter, especially in The post AI in Market Research: Why AI Can’t Replace Human Market Researchers (Yet) appeared first on iData Research.

For decades, injectable insulin and GLP-1 receptor agonists have been the gold standard in diabetes management. But for millions of patients, daily injections are painful, inconvenient, and often lead to poor adherence. Pharmaceutical companies are now shifting focus to needle-free, non-injectable alternatives, making diabetes care easier and less invasive. In this article, we will talk The post Non-Injectable Diabetes Medications and Treatments in 2025 appeared first on iData Research.